A randomized controlled, double-blind study of Chinese medicine combined with EGFR-TKI in the treatment of stage IV EGFR mutation-positive non-small cell lung cancer

Category Primary study
Registry of TrialsInternational Traditional Medicine Clinical Trial Registry
Year 2019
This article has no abstract
Epistemonikos ID: 1598a81fc207e0807256465916e5a836b4c18151
First added on: Apr 11, 2025